Turn this role into an interview — a resume and cover letter built around what this employer wants.
Xeltis is seeking the first dedicated in-house marketing hire to drive the European launch of aXess and build the function from the ground up. You will own sales enablement content, lead congress activities, and manage digital marketing and CRM.
This hybrid role is based at the High Tech Campus Eindhoven with cross-functional collaboration across physicians, hospitals, and decision-makers. Ideal candidates have 5–7 years in medical devices marketing, experience with regulated environments, and
Build the in-house marketing function as Xeltis takes aXess™, our CE-marked vascular access platform, to physicians across Europe. First marketing hire, growth path attached.
On 30 June 2026, Xeltis goes commercial. After more than a decade of development, multiple clinical trials, and CE Mark approval for aXess™, our vascular access platform for hemodialysis, we begin the first commercial launch in the company’s history.
You will be joining Xeltis at the moment the company transforms from clinical-stage to commercial. Your work will help shape how a genuinely novel vascular access implant reaches the patients who need it most. This is a real opportunity to be part of shaping Xeltis's next chapter.
This is the first dedicated marketing hire to lead the in-house execution of the European launch. You will work directly with our SVP Strategic Marketing & GTM and an established agency ecosystem covering brand and creative, PR, and design, with relationships already in place, to turn brand, positioning, and account strategy into the materials, congress experiences, and digital touchpoints that drive aXess adoption with physicians, hospitals, and clinical decision-makers across Europe.
For more than a decade we have built inside-out: developing the device, running the trials, securing approval. Your job is to help us turn outside-in.
That means grounding our marketing in what physicians, nurses, and hospital decision-makers actually need to choose aXess, and making sure that signal reaches every piece of work we produce.
The role spans three areas, in this order of priority:
Develop and maintain the materials our commercial team uses to engage physicians and hospital decision-makers: brochures, sell-sheets, presentations, leaflets, technical data sheets. Own the full content lifecycle from brief and draft through medical and regulatory review (MLR), translations into our priority markets (Germany, Iberia, others as they open), version control, and brand consistency.
This is the workstream that most directly enables our VP Commercial and the broader commercial team to hit their targets. It is your number one priority.
Lead the planning and on-site execution of our European congress presence in conjunction with our clinical team: booth, materials, KOL hosting, speaker activities, lead capture, and pre- and post-event activation. Congresses are where our customers are, and this is the most visible expression of the Xeltis brand in the market.
This work is currently being absorbed by colleagues whose primary roles sit elsewhere. You will take it over and elevate it to the standard our commercial moment demands.
Manage website content, SEO and AI-search optimization, our LinkedIn presence, and the digital asset library. Maintain CRM and marketing automation tooling for campaigns, KOL register, and lead tracking. Over time, bring routine digital execution in-house, reducing dependency on external agencies for work that is more efficient internally.
You will own day-to-day project management of our external agencies, develop creative briefs, manage timelines and deliverables, track agency budgets, and act as the in-house creative checkpoint. You may write when it helps, but the core of the role is guiding agencies, directing internal stakeholders, and managing customer-facing moments at events. You will talk to physicians and internal stakeholders alike, ask the right questions, and bring that signal back into the work.
Xeltis is a medical device company developing the world's most advanced polymer-based platform of restorative cardiovascular devices. Our devices naturally evolve into living blood vessels within the body through the patient’s own tissue.
We recently received CE Mark approval for aXess™, our vascular access platform for hemodialysis patients, and are entering early commercial launch across key European sites. Multiple clinical trials are ongoing. We are a team of 60+ people from across the world, headquartered at the High Tech Campus in Eindhoven, the Netherlands.
Improving patients’ lives is what we do. We work on something that matters, and we work like we mean it.